We estimate that the CEO of Chubb Ltd ($CB), Evan G. Greenberg, received a compensation of $33,180,582 in 2025. This is an increase of 9.17% from an estimated $30,138,094 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 03, 2026. Note that parsing errors may occur.
You can track $CB on Quiver Quantitative's $CB stock dashboard.
$CB Stock Insider Trading Activity
$CB Stock insiders have traded $CB stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 40,073 shares for an estimated $11,513,506.
- EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 29,985 shares for an estimated $9,993,140.
- JOSEPH F WAYLAND (Executive Vice President and*) has made 0 purchases and 2 sales selling 13,475 shares for an estimated $4,304,060.
- TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 2 sales selling 11,430 shares for an estimated $3,384,390.
- GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 3 sales selling 5,910 shares for an estimated $1,923,106.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 4,357 shares for an estimated $1,285,489
- OLIVIER STEIMER sold 2,000 shares for an estimated $658,600
- BRYCE L. JOHNS (Senior Vice President,*) sold 1,500 shares for an estimated $504,925
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CB Stock Congressional Stock Trading
Members of Congress have traded $CB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CB Stock Hedge Fund Activity
We have seen 925 institutional investors add shares of $CB Stock stock to their portfolio, and 807 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,049,987 shares (+25.6%) to their portfolio in Q4 2025, for an estimated $951,961,942
- BERKSHIRE HATHAWAY INC added 2,916,288 shares (+9.3%) to their portfolio in Q4 2025, for an estimated $910,231,810
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,548,307 shares (+inf%) to their portfolio in Q4 2025, for an estimated $795,377,580
- GQG PARTNERS LLC added 1,647,729 shares (+15.2%) to their portfolio in Q4 2025, for an estimated $514,289,175
- FMR LLC removed 1,468,730 shares (-11.9%) from their portfolio in Q4 2025, for an estimated $458,420,007
- AQR CAPITAL MANAGEMENT LLC added 1,443,335 shares (+51.6%) to their portfolio in Q4 2025, for an estimated $450,493,720
- VIKING GLOBAL INVESTORS LP added 1,013,839 shares (+inf%) to their portfolio in Q4 2025, for an estimated $316,439,428
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CB Stock Analyst Ratings
Wall Street analysts have issued reports on $CB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 01/08/2026
- Keefe, Bruyette & Woods issued a "Outperform" rating on 01/06/2026
- JMP Securities issued a "Market Outperform" rating on 10/22/2025
To track analyst ratings and price targets for $CB Stock, check out Quiver Quantitative's $CB forecast page.
$CB Stock Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 18 analysts offer price targets for $CB in the last 6 months, with a median target of $337.5.
Here are some recent targets:
- Cave Montazeri from Deutsche Bank set a target price of $330.0 on 03/23/2026
- Michael Zaremski from BMO Capital set a target price of $326.0 on 02/10/2026
- C. Gregory Peters from Raymond James set a target price of $380.0 on 02/09/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $373.0 on 02/09/2026
- Matthew Heimermann from Citigroup set a target price of $385.0 on 02/09/2026
- Yaron Kinar from Mizuho set a target price of $336.0 on 02/06/2026
- Elyse Greenspan from Wells Fargo set a target price of $322.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
